Literature DB >> 32014458

Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression.

Wei Chen1, Yingyao Quan2, Shaoyi Fan3, Hua Wang4, Jinyu Liang5, Li Huang1, Liuhua Chen1, Qi Liu1, Peiheng He6, Yibiao Ye7.   

Abstract

Extracellular communication in the tumor microenvironment is critical. Results of qRT-PCR show that circ-0051443 is significantly lower in the plasma exosomes and tissues from patients with hepatocellular carcinoma (HCC) than healthy controls. Compared with the producer cells, circ-0051443 is mainly packaged into exosomes. A receiver operating characteristic curve (ROC) shows that the patients with HCC can be distinguished from the controls by exosomal circ-0051443. The role of exosomal circ-0051443 in HCC was determined by animal and cell analyses. Circ-0051443 is transmitted from normal cells to HCC cells via exosomes and suppresses the malignant biological behaviors by promoting cell apoptosis and arresting the cell cycle. Exosomal circ-0051443 decreases the weight and volume of the xenograft tumors in nude mice via BAK1 upregulation in these tumors. BAK1 expression is mediated by exosomal circ-0051443 through competitive bound to miR-331-3p. Therefore, exosomal circ-0051443 can serve as a predictor and potential therapeutic target for HCC.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Extracellular vesicles; Liver cancer; circRNA; miRNA

Year:  2020        PMID: 32014458     DOI: 10.1016/j.canlet.2020.01.022

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  90 in total

1.  Exosomal circPVT1 derived from lung cancer promotes the progression of lung cancer by targeting miR-124-3p/EZH2 axis and regulating macrophage polarization.

Authors:  Ying Liu; Lei Li; Xiang Song
Journal:  Cell Cycle       Date:  2022-01-13       Impact factor: 4.534

Review 2.  Cancer metabolism and tumor microenvironment: fostering each other?

Authors:  Yiyuan Yuan; Huimin Li; Wang Pu; Leilei Chen; Dong Guo; Hongfei Jiang; Bo He; Siyuan Qin; Kui Wang; Na Li; Jingwei Feng; Jing Wen; Shipeng Cheng; Yaguang Zhang; Weiwei Yang; Dan Ye; Zhimin Lu; Canhua Huang; Jun Mei; Hua-Feng Zhang; Ping Gao; Peng Jiang; Shicheng Su; Bing Sun; Shi-Min Zhao
Journal:  Sci China Life Sci       Date:  2021-11-26       Impact factor: 6.038

Review 3.  Extracellular vesicles and particles impact the systemic landscape of cancer.

Authors:  Serena Lucotti; Candia M Kenific; Haiying Zhang; David Lyden
Journal:  EMBO J       Date:  2022-09-02       Impact factor: 14.012

Review 4.  Prospect of exosomal circular RNAs in breast Cancer: presents and future.

Authors:  Elham Zokaei; Farzaneh Darbeheshti; Nima Rezaei
Journal:  Mol Biol Rep       Date:  2022-05-09       Impact factor: 2.742

5.  Plasma Exosomal CircNEK9 Accelerates the Progression of Gastric Cancer via miR-409-3p/MAP7 Axis.

Authors:  Li Yu; Jie Xie; Xiaoming Liu; Yan Yu; Siping Wang
Journal:  Dig Dis Sci       Date:  2021-01-15       Impact factor: 3.199

Review 6.  Exosomes as therapeutic vehicles in liver diseases.

Authors:  Jingyi Ding; Ju Wang; Jiajia Chen
Journal:  Ann Transl Med       Date:  2021-04

Review 7.  Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.

Authors:  Yucheng Zhang; Yali Wang
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

8.  Exosomal circRNAs: a new communication method in cancer.

Authors:  Jia-Lin Xu; Wen-Xiu Xu; Jin-Hai Tang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 9.  Quantitative proteomics characterization of cancer biomarkers and treatment.

Authors:  Xiao-Li Yang; Yi Shi; Dan-Dan Zhang; Rui Xin; Jing Deng; Ting-Miao Wu; Hui-Min Wang; Pei-Yao Wang; Ji-Bin Liu; Wen Li; Yu-Shui Ma; Da Fu
Journal:  Mol Ther Oncolytics       Date:  2021-04-20       Impact factor: 7.200

Review 10.  Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma.

Authors:  Rui Liao; Lei Liu; Jian Zhou; Xufu Wei; Ping Huang
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.